NSE - Delayed Quote ? INR Lupin Limited (LUPIN.NS) Follow Compare 2,132.05 -19.90 (-0.92%) At close: 3:30 PM GMT+5:30 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Lupin and Takeda to commercialise Vonoprazan in India Vonoprazan will be made available in 10mg and 20mg strengths. Pharmaceutical Technology ? last month TAK LUPIN.BO Performance Overview Trailing total returns as of 10/22/2024, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX Return LUPIN.NS S&P BSE SENSEX YTD +61.87% +11.05% 1-Year +81.53% +22.67% 3-Year +134.13% +31.67%
